SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-14-003897
Filing Date
2014-04-17
Accepted
2014-04-17 16:07:20
Documents
6
Period of Report
2014-05-21
Effectiveness Date
2014-04-17

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2219534zdef14a.htm DEF 14A 671318
2 G775045.JPG g775045.jpg GRAPHIC 11606
3 G641197.JPG g641197.jpg GRAPHIC 8973
4 G368600.JPG g368600.jpg GRAPHIC 3453
5 G196472.JPG g196472.jpg GRAPHIC 6478
6 G74132BGI001.JPG g74132bgi001.jpg GRAPHIC 731
  Complete submission text file 0001047469-14-003897.txt   716148
Mailing Address 9363 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9363 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 (514) 337-3333
Mirati Therapeutics, Inc. (Filer) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35921 | Film No.: 14770178
SIC: 2834 Pharmaceutical Preparations